Richard Underwood gained a first class honours degree in chemistry at Merton College, University of Oxford which included a period working in George Radda's laboratory using NMR and ESR in biological systems. He went on to study medicine, graduating in 1977. After general medical training he specialised in cardiac medicine learning both noninvasive and invasive techniques, and for the last 20 years he has practised noninvasive cardiac imaging, with major clinical and research interests in nuclear cardiology, magnetic resonance and in cardiovascular X-ray computed tomography.
Since 1985, Professor Underwood has worked at Royal Brompton Hospital, London and its academic wing, the National Heart and Lung Institute, Imperial College School of Medicine. He has been closely involved in the development of magnetic resonance techniques for the investigation of the cardiovascular system, and has contributed substantially to its progression from research technique to every-day clinical tool. His current research interests include the assessment of myocardial perfusion using pharmacological stress, the characterisation of hibernating myocardium, and the cost-effectiveness of cardiac imaging techniques. He has published and lectured widely and has directed or co-directed important training courses on nuclear cardiology at national and international level.
He is professor of cardiac imaging at the National Heart and Lung Institute, Imperial College London, and honorary consultant and director of nuclear medicine at Royal Brompton & Harefield Hospitals. External commitments include past-chairman of the ESC working group on nuclear cardiology and magnetic resonance, past-chair of the British Nuclear Cardiology Society and the International Congress of Nuclear Cardiology, and current member of the European Council on Nuclear Cardiology.
Non-medical interests include aviation, skiing and gastronomy.
et al., 2020, No evidence electric charge increases inhaled ultrafine particle deposition in human lungs., American Journal of Respiratory and Critical Care Medicine, ISSN:1073-449X
et al., 2020, Impact of scan quality on the diagnostic performance of CCTA, SPECT, and PET for diagnosing myocardial ischemia defined by fractional flow reserve, Journal of Cardiovascular Computed Tomography, Vol:14, ISSN:1934-5925, Pages:60-67
Reyes E, Underwood SR, 2020, Regadenoson myocardial perfusion scintigraphy for the evaluation of coronary artery disease in patients with lung disease: A series of five cases, Journal of Nuclear Cardiology, Vol:27, ISSN:1071-3581, Pages:315-321
et al., 2019, Cost-effectiveness analysis of stand-alone or combined non-invasive imaging tests for the diagnosis of stable coronary artery disease: results from the EVINCI study, European Journal of Health Economics, Vol:20, ISSN:1618-7598, Pages:1437-1449
et al., 2019, Data on the impact of scan quality on the diagnostic performance of CCTA, SPECT, and PET for diagnosing myocardial ischemia defined by fractional flow reserve on a per vessel level, Data in Brief, Vol:27, ISSN:2352-3409